In the works of Zaletel et al. [13], there are indications of the possibility of indirect determination of IR and severity of metabolic syndrome by the ratio of adiponectin/leptin (A/L), which is a more effective indicator of IP than a single determination of adiponectin, leptin or HOMA-IR in patients without diabetes. The gene discussed is ADIPOQ; the disease is metabolic syndrome.